BlackRock »

Acrivon Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2023-09-30 $5.1M 529k 9.56
2023-06-30 $6.9M 533k 12.96
2023-03-31 $6.0M 474k 12.69